[THE EXPERTS CONSENSUS FOR ANTICOAGULANT THERAPY OF VENOUS THROMBOEMBOLISM IN 2016 YR. SIGNIFICANCE OF THE RIVAROXABAN INVESTIGATIONS PROGRAM FOR CHANGES OF APPROACHES, CONCERNING TREATMENT OF THE DEEP VEINS THROMBOSIS AND PULMONARY THROMBOEMBOLISM]

MeSH terms

• Anticoagulants / therapeutic use*
• Consensus
• Disease Management
• Drug Administration Schedule
• Drug Dosage Calculations
• Humans
• Neoplasms / blood
• Neoplasms / complications
• Neoplasms / drug therapy*
• Neoplasms / pathology
• Practice Guidelines as Topic
• Pulmonary Embolism / blood
• Pulmonary Embolism / complications
• Pulmonary Embolism / pathology
• Pulmonary Embolism / prevention & control*
• Rivaroxaban / therapeutic use*
• Stroke / blood
• Stroke / complications
• Stroke / drug therapy*
• Stroke / pathology
• Venous Thromboembolism / blood
• Venous Thromboembolism / complications
• Venous Thromboembolism / pathology
• Venous Thromboembolism / prevention & control*
• Venous Thrombosis / blood
• Venous Thrombosis / complications
• Venous Thrombosis / drug therapy*
• Venous Thrombosis / pathology